Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2013
07/16/2013CA2600560C Method for producing plant forming nodules with high nitrogen-fixing activity
07/16/2013CA2547320C Fatty acid elongase (fae) genes and their utility in increasing erucic acid and other very long-chain fatty acid proportions in seed oil
07/16/2013CA2516834C Polypeptides and methods for making the same
07/16/2013CA2487322C Animal genotyping method
07/16/2013CA2476890C Subtilisin carlsberg proteins with reduced immunogenicity
07/16/2013CA2372991C Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and related fatty acids having a modification at the delta-9 position
07/16/2013CA2350334C New family of mammalian potassium channels, their cloning and their use, especially for the screening of drugs
07/16/2013CA2330231C Composition and method for modulating dendritic cell-t cell interaction
07/16/2013CA2289742C Method for generating activated t-cells and antigen-pulsed antigen-presenting cells
07/16/2013CA2253441C Glycoprotein hormone superagonists
07/11/2013WO2013103883A1 Methods of using mechanical force with somatic and pluripotent cells
07/11/2013WO2013103367A1 Somatic ovule specific promoter and methods of use
07/11/2013WO2013103362A1 Antigen-presenting platelets and methods of eliciting an immune response
07/11/2013WO2013103156A1 Method for sorting of pluripotent cells
07/11/2013WO2013103108A1 Cell separation container
07/11/2013WO2013103089A1 Culture method for maintenance and propagation of stem cells by lysophospholipid signal control
07/11/2013WO2013103053A1 DEVELOPMENT OF SIMPLE DISCRIMINATION METHOD FOR LOW-QUALITY ES CELLS AND iPS CELLS AS INDICATOR OF BIOLOGICAL CLOCK, AND DEVELOPMENT OF CELL EVALUATION METHOD AS INDICATOR OF BIOLOGICAL CLOCK
07/11/2013WO2013102904A1 Methods and compositions for gene delivery
07/11/2013WO2013102882A2 Cosmetic use of dedifferentiated plant cells
07/11/2013WO2013066802A3 Compositions and methods for lung regeneration
07/11/2013WO2013025963A3 Conversion of somatic cells into functional spinal motor neurons, and methods and uses thereof
07/11/2013WO2013020087A3 Nucleic acid compositions, methods and kits for rapid pairing of affinity agents
07/11/2013WO2013019681A3 Selective delivery molecules and methods of use
07/11/2013WO2013019625A3 Methods of using a bacterial glcnac-6-p 2'-epimerase to promote sialylation of glycoconjugates
07/11/2013WO2013013105A3 Compositions and methods for re-programming cells without genetic modification for repairing cartilage damage
07/11/2013WO2013009595A9 Injectable cns-derived ecm for tissue reconstruction
07/11/2013WO2012174467A3 Cord blood-derived neurons by expression of sox2
07/11/2013US20130180010 Methods and Compositions for Modulating Expression or Activity of a RKD Polypeptide in a Plant
07/11/2013US20130180006 Pollen Preferred Promoters and Methods of Use
07/11/2013US20130180003 Sweet corn line syw-6r07086
07/11/2013US20130180000 Cotton cultivar ua222
07/11/2013US20130179997 Transgenic animal expressing alzheimer's tau protein
07/11/2013US20130178543 Biomarker for diagnosing cancer and method of isolating cancer cell using the same
07/11/2013US20130178418 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
07/11/2013US20130177987 Methods for developing antigen-specific antibody-producing cell lines and monoclonal antibodies
07/11/2013US20130177986 Pancreatic islet separation method, and protective solution for protecting pancreatic islet tissue
07/11/2013US20130177985 DNA Sequence Encoding a Retinoic Acid Regulated Protein
07/11/2013US20130177984 Tumor Suppressor Gene, p28ING5
07/11/2013US20130177982 Interleukin-1 Alpha Antibodies and Methods of Use
07/11/2013US20130177980 Synthetic matrices for self-renewal and expansion of stem cells
07/11/2013US20130177929 Method for the three-dimensional co- culture of podocytes and endothelial cells and relative in vitro co- culture system
07/11/2013US20130177912 Selective oxidation of 5-methylcytosine by tet-family proteins
07/11/2013US20130177600 Materials and Methods for Altering an Immune Response to Exogenous and Endogenous Immunogens, Including Syngeneic and Non-Syngeneic Cells, Tissues or Organs
07/11/2013US20130177541 Modified factor IX polypeptides and uses thereof
07/11/2013US20130177537 Stem cells and methods for incorporating environmental factors as a means for enhancing stem cell proliferation and plasticity
07/11/2013US20130177535 Wnt inhibitors for human stem cell differentiation
07/11/2013US20130177525 Cancer therapy based on tumor associated antigens derived from cyclin d1
07/11/2013DE102010025294B4 Verfahren zur Isolierung paradontaler Stammzellen A method for isolating stem cells periodontal
07/10/2013EP2612912A1 Protein having glycoalkaloid biosynthetic enzyme activity and gene encoding the same
07/10/2013EP2612911A1 Composition for inducing pluripotent stem cell, and use thereof
07/10/2013EP2612909A1 Method for producing virus vector
07/10/2013EP2612908A2 Optically sensitive cell network
07/10/2013EP2612907A1 Preparation of cell transplant
07/10/2013EP2612906A2 Derivation of embryonic stem cells and embryo-derived cells
07/10/2013EP2612678A1 Screening method for antidiabetic agent using newly identified insulin secretion regulation factor
07/10/2013EP2612675A1 Treatment of development-related disorders
07/10/2013EP2611914A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
07/10/2013EP2611910A2 Differentiation of human embryonic stem cells
07/10/2013EP2611909A2 Differentiation of human embryonic stem cells
07/10/2013EP2611908A1 Cell culture screen for agents that control adipogenesis and myofibroblast differentiation
07/10/2013EP2611907A2 Differentiation of pluripotent stem cells
07/10/2013EP2611906A1 Systemic, allogenic stem cell therapies for treatment of diseases in animals
07/10/2013EP2611905A1 Ebv-specific cytotoxic t-lymphocytes for the treatment of locoregional nasopharyngeal carcinoma (npc)
07/10/2013EP2611904A2 Culture medium for eukaryotic cells
07/10/2013EP2611902A2 Compositions and methods for modulating emt and uses thereof
07/10/2013EP2611452A2 Cell culture system for bioreactor scale-up of cells
07/10/2013EP2611384A2 Blood vessel grafts for repair, reconstruction and filler materials
07/10/2013CN1671425B ACE2 activation for treatment of heart, lung and kidney disease and hypertension
07/10/2013CN1541109B Inhibitors of HER3 activity
07/10/2013CN103201383A 改性荧光蛋白 Modified fluorescent protein
07/10/2013CN103201382A Novel expression vector
07/10/2013CN103201378A Compositions and methods for producing dendritic cells
07/10/2013CN103201377A Method for controlling binding of cells to a substrate
07/10/2013CN103201291A Anti single-strand type-iv collagen polypeptide antibody, and pharmaceutical, or agent for diagnosing, preventing or treating tumours, containing same
07/10/2013CN103201286A Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (alk) kinase inhibitors
07/10/2013CN103200972A Method for producing a bone transplant material, and bone transplant material produced by same
07/10/2013CN103200960A Vaccine against ehrlichia canis and associated methods
07/10/2013CN103197076A Biomarker for diagnosing cancer and method of isolating cancer cell using the same
07/10/2013CN103194460A Preparation method of bacillus thuringiensis crystal fusion protein Bt Cry3Bb
07/10/2013CN103194453A Method for improving plant traits
07/10/2013CN103194451A Specific expression promoter of rice seed aleurone layer and application thereof
07/10/2013CN103194445A DNA (Deoxyribonucleic acid) segment and applications thereof in constructing HCV (hepatitis C virus) whole-genome expression animal model
07/10/2013CN103194430A Hybridoma capable of secreting anti-CA125 protein monoclonal antibody and application of hybridoma
07/10/2013CN103194429A Culturing and construction of human gastric cancer tumor stem cell line GAM-016S
07/10/2013CN103194428A Culture method for in vitro differentiating and amplifying human natural killer cells through insulin-like growth factors and various cell factors
07/10/2013CN103194427A Mononuclear cell and cell factor in-vitro concentration kit and application thereof
07/10/2013CN103194426A Preparation of cell transplant
07/10/2013CN103194425A Method for promoting epidermal cell proliferation
07/10/2013CN103194424A Method for inducing embryonic stem cell into pancreatic tissue-like cells
07/10/2013CN103194423A Medium and purpose thereof
07/10/2013CN103194422A Method for extracting carrot pollen microspores
07/10/2013CN103194389A Device and method for in vitro high-density cultivation of erythrocyte
07/10/2013CN103194369A Rockable biocontainer
07/10/2013CN103193885A Anti-EPHRINB2 antiboies and methods using same
07/10/2013CN103193882A Embryonic stem cell specific marker GM-CSFR alpha and application thereof
07/10/2013CN103193875A Paddy chloroplast growth related protein as well as coding gene and application thereof
07/10/2013CN103193874A Secretory elicitor protein from Verticillium dahliae and coding gene and application thereof
07/10/2013CN103193872A Haemophilus parasuis OppA recombinant protein antigen-containing forward haemophilus parasuis disease indirect hamagglutination diagnosis reagent and preparation method thereof
07/10/2013CN103191466A Method for preparing human body or animal accellular tissues
07/10/2013CN103191445A Use of mesenchymal stem cell and preparation method thereof